Related Experiment Video
Updated: Dec 15, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Dysregulation of cancer genes by recurrent intergenic fusions
Jae Won Yun1,2,3, Lixing Yang4,5, Hye-Young Park6
1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea.
Background:
Gene fusions have been studied extensively, as frequent drivers of tumorigenesis as well as potential therapeutic targets. In many well-known cases, breakpoints occur at two intragenic positions, leading to in-frame gene-gene fusions that generate chimeric mRNAs. However, fusions often occur with intergenic breakpoints, and the role of such fusions has not been carefully examined.
Results:
We analyze whole-genome sequencing data from 268 patients to catalog gene-intergenic and intergenic-intergenic fusions and characterize their impact. First, we discover that, in contrast to the common assumption, chimeric oncogenic transcripts-such as those involving ETV4, ERG, RSPO3, and PIK3CA-can be generated by gene-intergenic fusions through splicing of the intervening region. Second, we find that over-expression of an upstream or downstream gene by a fusion-mediated repositioning of a regulatory sequence is much more common than previously suspected, with enhancers sometimes located megabases away. We detect a number of recurrent fusions, such as those involving ANO3, RGS9, FUT5, CHI3L1, OR1D4, and LIPG in breast; IGF2 in colon; ETV1 in prostate; and IGF2BP3 and SIX2 in thyroid cancers.
Conclusion:
Our findings elucidate the potential oncogenic function of intergenic fusions and highlight the wide-ranging consequences of structural rearrangements in cancer genomes.
Insights
Intergenic gene fusions, previously overlooked, can create oncogenic transcripts and alter gene expression, significantly impacting cancer development. This study reveals their widespread role in tumorigenesis.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Gene fusions are established drivers of cancer and therapeutic targets.
- Intragenic breakpoints leading to chimeric mRNAs are well-documented.
- The role of intergenic breakpoints in gene fusions remains largely unexplored.
Purpose of the Study:
- To catalog gene-intergenic and intergenic-intergenic fusions.
- To characterize the impact of these fusions on cancer genomes.
- To investigate the mechanisms by which intergenic fusions contribute to tumorigenesis.
Main Methods:
- Analysis of whole-genome sequencing data from 268 cancer patients.
- Identification and cataloging of gene-intergenic and intergenic-intergenic fusion events.
- Characterization of the functional impact of identified fusions.
Main Results:
- Gene-intergenic fusions can generate chimeric oncogenic transcripts (e.g., ETV4, ERG, RSPO3, PIK3CA) via splicing.
- Fusion-mediated repositioning of regulatory elements (enhancers) leading to gene overexpression is common.
- Recurrent intergenic fusions were identified across various cancer types (breast, colon, prostate, thyroid).
Conclusions:
- Intergenic fusions possess significant oncogenic potential.
- Structural rearrangements involving intergenic regions have broad consequences in cancer.
- This study highlights the importance of examining intergenic alterations in cancer genomics.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

